Completing data — refresh the page later to see the latest
3159-07-7O=C1Nc2ccccc2Sc2ccccc21RTERDTBXBYNZIS-UHFFFAOYSA-N3159-07-7DTXSID10953553CHEMBL598054Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 70% (7 of 10) of all reports.
Warning
H302 (20%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 10 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Warning
REACH registered substance: dibenzo[b,f][1,4]thiazepin-11(10H)-one (EC: 438-020-0)
REACH registered substance: Dibenzo-(b,f)(1,4)Thiazepine-11(10H)-one (EC: 608-646-0)
Acute Tox. 4 (20%)
Skin Irrit. 2 (16.7%)
UsesDibenzo[b,f][1,4]thiazepine-11-[10H]one (Quetiapine EP Impurity G; Quetiapine Impurity G; Quetiapine USP-G) is an intermediate in the synthesis of quetiapine (Q510000).